国际皮肤性病学杂志    2007 33 (6): 352-354   ISSN: 2096-5540  CN: 32-1880/R   儿童系统性红斑狼疮的进展 陈秋萍, 王培光, 杨森, 张学军 安徽医科大学第一附属医院皮肤性病科, 230022 收稿日期 2007-03-02  修回日期 null  网络版发布日期 null 参考文献  [1] Tucker LB,Menon S,Schaller JG,et al.Adult-and childhood-onset systemic lupus erythematosus:a comparison of onset,clinical features,serology,and outcome.Br J Rheumatol,1995,34(9):866-872. [2] Klein-Gitelman M,Reeiff A,Silverman ED.Systemic lupus erythe matosus in childhood.Rheum Dis Clim North Am,2002,28(3):561-577,vi-vii. [3] Guevara JP,Clark BJ,Athreya BH.Point prevalence of cardiac abnormalities in children with systemic lupus erythematosus.J Rheumatol,2001,28(4):854-859. [4] Arkachaisri T,Lehman TJ.Systemic lupus erythematosus and related disorders of childhood.Curr Opin Rheumatol,1999,11(5):384-392. [5] Trapani S,Camiciottoli G,Ermini M,et al Pulmonary involvement in juvenile systemic lupus erythematosus:a study on lung function in patients asymptomatic for respiratory disease.Lupus,1998,7(8):545-550. [6] Bogdanovic R,Nikolic V,Pasic S,et al.Lupus nephritis in childhood:a review Of 53 patients followed at a single center.Pediatr Nephrol,2004,19(1):36-44. [7] Bakkaloglu A.Lupus nephropathy in children.Nephrol Dial Transplant,2001,16(Suppl 6):126-128. [8] Zappitelli M,Duffy C,Bernard C,et al.Clinicopathological study of the WH0 classification in childhood lupus nephritis.Pediatr Nephrol,2004,19(5):503-510. [9] Schmugge M,Revel-Vilk S,Hiraki L,et al.Thrombocytopenia and thromboembolism in pediatric systemic lupus erythematosus.J Pediatr,2003,143(5):666-669. [10] Tseng CE,Buyon JP,Kim M,et al.The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active,but clinically stable,systemic lupus erythematosus:findings of a prospective,randomized,double-blind,placebo-controlled trial.Arthritis Rheum,2006,54(11):3378-3380. [11] Carreno L,Lopez-Longo FJ,Gonzalez CM,et al.Treatment options for iuvenile-onset systemic lupus erythematosus.Paediatr Drugs,2002,4(4):241-256. [12] Mavrikakis I,Sfikakis PP,Mavrikakis E,et al.The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine:a reappraisal.Ophthalmology,2003,110(7):1321-1326. [13] Fessler BJ,Alarcon GS,McGwin G Jr,et al.Systemic lupus erythematosus in three ethnic groups:XVI.Association of hydroxychloroquine use with reduced risk of damage accrual.Arthritis Rheum,2005,52(5):1473-1480. [14] Illei GG,Austin HA,Crane M,et al.Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.Ann Intern Med,2001,135(4):248-257. [15] Filler G,Hansen M,LeBlanc C,et al.Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children.Pediatr Nephrol,2003,18(5):445-449. [16] Chen TM,Tse KC,Tang CS,et al.Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.J Am Soc Nephrol,2005,16(4):1076-1084. [17] Yoshidome K,Takei S,Imenaka H,et al.Efficacy of mizoribine in the treatment of systemic lupus erythematosus in children.Pediatr Int,2004,46(4):444-449. [18] Tanaka H,PeTsugawa K,Suzuki K,et al.Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.Pediatr Nephrol,2006,2l(7):962-966. [19] Willems M,Haddad E,Niaudet P,et al.Rituximab therapy for childhood-onset systemic lupus erythematosus.J Pediatr,2006,148(5):571-573. [20] Jensson AF,Wintergerst U,Renner ED,et al.Rituximab-induced long-term remission in two children with SLE.Eur J Pediatr,2007,166(2):177-181. [21] Kamali S,Cefle A,Sayarlioglu M,et al.Experience with monthly,high-dose,intravenous immunoglobulin therapy in patients with difierent connective tissue diseases.Rheumatol Int,2005,25(3):211-214. 通讯作者: 张学军, email:ayzxj@vip.sina.com